About the journal
ClinicoEconomics and Outcomes Research is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1178-6981
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,565 USD
- Articles in DOAJ
- 1007
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2010-01-11
- PUBMED · 2013-09-23
- Indexing
- DOAJ · PUBMED
- APC
- 3,565 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1007
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
1035
Last recorded publication year
2026
h-index
52
i10-index
478
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2010-01-11
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 89%
- ORCID iDs in current deposits
- 88%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101560564
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Healthcare Systems and Reforms
- Healthcare Systems and Reforms
Show all subjects (50)
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Global Maternal and Child Health
- Global Maternal and Child Health
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Heart Failure Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Heart Failure Treatment and Management
- Spine and Intervertebral Disc Pathology
- Spine and Intervertebral Disc Pathology
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Diabetes Management and Research
- Diabetes Management and Research
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Multiple Sclerosis Research Studies
- HIV/AIDS Research and Interventions
- Global Health Care Issues
- Lung Cancer Treatments and Mutations
- Multiple Sclerosis Research Studies
- HIV/AIDS Research and Interventions
- Atrial Fibrillation Management and Outcomes
- Global Health Care Issues
- Lung Cancer Treatments and Mutations
- Atrial Fibrillation Management and Outcomes
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Primary Care and Health Outcomes
- Primary Care and Health Outcomes
- Psoriasis: Treatment and Pathogenesis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Psoriasis: Treatment and Pathogenesis
Keywords (DOAJ)
- health technology assessment
- pharmacoeconomics
- health systems
- health policy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ